221 related articles for article (PubMed ID: 27145464)
1. Clinical, Pathological, and Molecular Characterization of Infant Medulloblastomas Treated with Sequential High-Dose Chemotherapy.
Lafay-Cousin L; Smith A; Chi SN; Wells E; Madden J; Margol A; Ramaswamy V; Finlay J; Taylor MD; Dhall G; Strother D; Kieran MW; Foreman NK; Packer RJ; Bouffet E
Pediatr Blood Cancer; 2016 Sep; 63(9):1527-34. PubMed ID: 27145464
[TBL] [Abstract][Full Text] [Related]
2. Medulloblastoma in China: clinicopathologic analyses of SHH, WNT, and non-SHH/WNT molecular subgroups reveal different therapeutic responses to adjuvant chemotherapy.
Zhang ZY; Xu J; Ren Y; Li KK; Ng HK; Mao Y; Zhong P; Yao Y; Zhou LF
PLoS One; 2014; 9(6):e99490. PubMed ID: 24932704
[TBL] [Abstract][Full Text] [Related]
3. Risk-adapted therapy for young children with medulloblastoma (SJYC07): therapeutic and molecular outcomes from a multicentre, phase 2 trial.
Robinson GW; Rudneva VA; Buchhalter I; Billups CA; Waszak SM; Smith KS; Bowers DC; Bendel A; Fisher PG; Partap S; Crawford JR; Hassall T; Indelicato DJ; Boop F; Klimo P; Sabin ND; Patay Z; Merchant TE; Stewart CF; Orr BA; Korbel JO; Jones DTW; Sharma T; Lichter P; Kool M; Korshunov A; Pfister SM; Gilbertson RJ; Sanders RP; Onar-Thomas A; Ellison DW; Gajjar A; Northcott PA
Lancet Oncol; 2018 Jun; 19(6):768-784. PubMed ID: 29778738
[TBL] [Abstract][Full Text] [Related]
4. Strategy to minimize radiation burden in infants and high-risk medulloblastoma using intrathecal methotrexate and high-dose chemotherapy: A prospective registry study in Japan.
Yamasaki K; Okada K; Soejima T; Sakamoto H; Hara J
Pediatr Blood Cancer; 2020 Jan; 67(1):e28012. PubMed ID: 31544362
[TBL] [Abstract][Full Text] [Related]
5. Outcomes of salvage re-irradiation in recurrent medulloblastoma correlate with age at initial diagnosis, primary risk-stratification, and molecular subgrouping.
Gupta T; Maitre M; Sastri GJ; Krishnatry R; Shirsat N; Epari S; Sahay A; Chinnaswamy G; Patil V; Shetty P; Moiyadi A
J Neurooncol; 2019 Sep; 144(2):283-291. PubMed ID: 31236820
[TBL] [Abstract][Full Text] [Related]
6. Promising survival rate but high incidence of treatment-related mortality after reduced-dose craniospinal radiotherapy and tandem high-dose chemotherapy in patients with high-risk medulloblastoma.
Lee JW; Lim DH; Sung KW; Cho HW; Ju HY; Hyun JK; Yoo KH; Koo HH; Suh YL; Joung YS; Shin HJ
Cancer Med; 2020 Aug; 9(16):5807-5818. PubMed ID: 32608158
[TBL] [Abstract][Full Text] [Related]
7. Adjuvant chemotherapy and overall survival in adult medulloblastoma.
Kann BH; Lester-Coll NH; Park HS; Yeboa DN; Kelly JR; Baehring JM; Becker KP; Yu JB; Bindra RS; Roberts KB
Neuro Oncol; 2017 Feb; 19(2):259-269. PubMed ID: 27540083
[TBL] [Abstract][Full Text] [Related]
8. Phase II Study of Nonmetastatic Desmoplastic Medulloblastoma in Children Younger Than 4 Years of Age: A Report of the Children's Oncology Group (ACNS1221).
Lafay-Cousin L; Bouffet E; Strother D; Rudneva V; Hawkins C; Eberhart C; Horbinski C; Heier L; Souweidane M; Williams-Hughes C; Onar-Thomas A; Billups CA; Fouladi M; Northcott P; Robinson G; Gajjar A
J Clin Oncol; 2020 Jan; 38(3):223-231. PubMed ID: 31774708
[TBL] [Abstract][Full Text] [Related]
9. Nonmetastatic Medulloblastoma of Early Childhood: Results From the Prospective Clinical Trial HIT-2000 and An Extended Validation Cohort.
Mynarek M; von Hoff K; Pietsch T; Ottensmeier H; Warmuth-Metz M; Bison B; Pfister S; Korshunov A; Sharma T; Jaeger N; Ryzhova M; Zheludkova O; Golanov A; Rushing EJ; Hasselblatt M; Koch A; Schüller U; von Deimling A; Sahm F; Sill M; Riemenschneider MJ; Dohmen H; Monoranu CM; Sommer C; Staszewski O; Mawrin C; Schittenhelm J; Brück W; Filipski K; Hartmann C; Meinhardt M; Pietschmann K; Haberler C; Slavc I; Gerber NU; Grotzer M; Benesch M; Schlegel PG; Deinlein F; von Bueren AO; Friedrich C; Juhnke BO; Obrecht D; Fleischhack G; Kwiecien R; Faldum A; Kortmann RD; Kool M; Rutkowski S
J Clin Oncol; 2020 Jun; 38(18):2028-2040. PubMed ID: 32330099
[TBL] [Abstract][Full Text] [Related]
10. Bridging the treatment gap in infant medulloblastoma: molecularly informed outcomes of a globally feasible regimen.
Baroni LV; Sampor C; Gonzalez A; Lubieniecki F; Lamas G; Rugilo C; Bartels U; Heled A; Smith KS; Northcott PA; Bouffet E; Alderete D; Ramaswamy V
Neuro Oncol; 2020 Dec; 22(12):1873-1881. PubMed ID: 32413139
[TBL] [Abstract][Full Text] [Related]
11. Treatment of Children and Adolescents With Metastatic Medulloblastoma and Prognostic Relevance of Clinical and Biologic Parameters.
von Bueren AO; Kortmann RD; von Hoff K; Friedrich C; Mynarek M; Müller K; Goschzik T; Zur Mühlen A; Gerber N; Warmuth-Metz M; Soerensen N; Deinlein F; Benesch M; Zwiener I; Kwiecien R; Faldum A; Bode U; Fleischhack G; Hovestadt V; Kool M; Jones D; Northcott P; Kuehl J; Pfister S; Pietsch T; Rutkowski S
J Clin Oncol; 2016 Dec; 34(34):4151-4160. PubMed ID: 27863192
[TBL] [Abstract][Full Text] [Related]
12. Exclusive Hyperfractionated Radiation Therapy and Reduced Boost Volume for Standard-Risk Medulloblastoma: Pooled Analysis of the 2 French Multicentric Studies MSFOP98 and MSFOP 2007 and Correlation With Molecular Subgroups.
Carrie C; Kieffer V; Figarella-Branger D; Masliah-Planchon J; Bolle S; Bernier V; Laprie A; Supiot S; Leseur J; Habrand JL; Alapetite C; Kerr C; Dufour C; Claude L; Chapet S; Huchet A; Bondiau PY; Escande A; Truc G; Nguyen TD; Pasteuris C; Vigneron C; Muracciole X; Bourdeaut F; Appay R; Dubray B; Colin C; Ferlay C; Dussart S; Chabaud S; Padovani L; ;
Int J Radiat Oncol Biol Phys; 2020 Dec; 108(5):1204-1217. PubMed ID: 32768563
[TBL] [Abstract][Full Text] [Related]
13. Outcome of medulloblastoma in children treated with reduced-dose radiation therapy plus adjuvant chemotherapy.
Sirachainan N; Nuchprayoon I; Thanarattanakorn P; Pakakasama S; Lusawat A; Visudibhan A; Dhanachai M; Larbcharoensub N; Amornfa J; Shotelersuk K; Katanyuwong K; Tangkaratt S; Hongeng S
J Clin Neurosci; 2011 Apr; 18(4):515-9. PubMed ID: 21310618
[TBL] [Abstract][Full Text] [Related]
14. Treatment of children with medulloblastomas with reduced-dose craniospinal radiation therapy and adjuvant chemotherapy: A Children's Cancer Group Study.
Packer RJ; Goldwein J; Nicholson HS; Vezina LG; Allen JC; Ris MD; Muraszko K; Rorke LB; Wara WM; Cohen BH; Boyett JM
J Clin Oncol; 1999 Jul; 17(7):2127-36. PubMed ID: 10561268
[TBL] [Abstract][Full Text] [Related]
15. Long-term neuropsychological follow-up of young children with medulloblastoma treated with sequential high-dose chemotherapy and irradiation sparing approach.
Fay-McClymont TB; Ploetz DM; Mabbott D; Walsh K; Smith A; Chi SN; Wells E; Madden J; Margol A; Finlay J; Kieran MW; Strother D; Dhall G; Packer RJ; Foreman NK; Bouffet E; Lafay-Cousin L
J Neurooncol; 2017 May; 133(1):119-128. PubMed ID: 28405869
[TBL] [Abstract][Full Text] [Related]
16. Chemotherapy for children with medulloblastoma.
Michiels EM; Schouten-Van Meeteren AY; Doz F; Janssens GO; van Dalen EC
Cochrane Database Syst Rev; 2015 Jan; 1(1):CD006678. PubMed ID: 25879092
[TBL] [Abstract][Full Text] [Related]
17. Treatment of early childhood medulloblastoma by postoperative chemotherapy and deferred radiotherapy.
Rutkowski S; Gerber NU; von Hoff K; Gnekow A; Bode U; Graf N; Berthold F; Henze G; Wolff JE; Warmuth-Metz M; Soerensen N; Emser A; Ottensmeier H; Deinlein F; Schlegel PG; Kortmann RD; Pietsch T; Kuehl J;
Neuro Oncol; 2009 Apr; 11(2):201-10. PubMed ID: 18818397
[TBL] [Abstract][Full Text] [Related]
18. Long-term outcomes and role of chemotherapy in adults with newly diagnosed medulloblastoma.
Call JA; Naik M; Rodriguez FJ; Giannini C; Wu W; Buckner JC; Parney IF; Laack NN
Am J Clin Oncol; 2014 Feb; 37(1):1-7. PubMed ID: 23111362
[TBL] [Abstract][Full Text] [Related]
19. Adjuvant chemotherapy after reduced craniospinal irradiation dose in children with average-risk medulloblastoma: a 5-year follow-up study.
Wahba HA; Abu-Hegazy M; Wasel Y; Ismail EI; Zidan AS
J BUON; 2013; 18(2):425-9. PubMed ID: 23818356
[TBL] [Abstract][Full Text] [Related]
20. [High-dose chemotherapy in relapse of medulloblastoma in young children].
Dupuis-Girod S; Hartmann O; Benhamou E; Doz F; Mechinaud F; Bouffet E; Coze C; Kalifa C
Bull Cancer; 1997 Mar; 84(3):264-72. PubMed ID: 9207872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
